Shunt-current reduction housing for an implantable therapy system

• US 8,473,057 B2
• Filed: 10/30/2009
• Issued: 06/25/2013
• Est. Priority Date: 10/31/2008
• Status: Active Grant

• Current Assignee: Medtronic Incorporated (Medtronic Plc)
• Original Assignee: Medtronic Incorporated (Medtronic Plc)
• Inventors: Donofrio, William T., Havel, William J., Christiansen, Chris C., Krause, Paul G.
• Primary Examiner(s): Layno, Carl H
• Assistant Examiner(s): Stice, Paula J
• Application Number:
  US12/609,901
• Publication Number:
  US 20100114205A1
• Time in Patent Office: 1,334 Days
• Field of Search: 607/2, 607/4, 607/36, 607/60
• US Class Current: 607/36
• CPC Class Codes: A61N 1/36114 Cardiac control, e.g. by vagal stimulation stimulating the heart A61N1/362
• CPC Class Codes: A61N 1/37 Monitoring; Protecting
• CPC Class Codes: A61N 1/3718 Monitoring of or protection against external electromagnetic fields or currents
• CPC Class Codes: A61N 1/37211 Means for communicating with stimulators
• CPC Class Codes: A61N 1/37288 Communication to several implantable medical devices within one patient
• CPC Class Codes: A61N 1/37512 Pacemakers
• CPC Class Codes: A61N 1/3925 Monitoring; Protecting
• CPC Class Codes: A61N 1/39622 Pacing therapy

Abstract

Techniques for minimizing interference between first and second medical devices of a therapy system may include providing an outer housing for at least one of the medical devices that comprises an electrically insulative layer formed over at least the electrically conductive portions (e.g., an electrically conductive layer) of the housing, or providing an electrically insulative pouch around an electrically conductive housing of at least the first medical device. The electrically insulative layer or electrically insulative pouch may reduce or even eliminate shunt-current that flows into the medical device via the housing. The shunt-current may be generated by the delivery of electrical stimulation by the second medical device. In some examples, the techniques may also include shunt-current mitigation circuitry that helps minimize or even eliminate shunt-current that feeds into the first medical device via one or more electrodes electrically connected to the first medical device.

Claims

1. A system comprising:

a first implantable medical device (IMD) configured to deliver electrical stimulation to a first tissue site within a patient, wherein the first IMD comprises an outer housing that includes;

an electrically conductive layer comprising an internal surface and an external surface; and

an electrically insulative layer substantially fully covering at least one of the internal surface or the external surface of the electrically conductive layer, wherein the electrically insulative layer is configured to mitigate electrical shunt-current flowing through the outer housing of the first IMD; and

a second IMD configured to deliver electrical stimulation to a second tissue site within the patient.

2. The system of claim 1, wherein the second implantable medical device (IMD) is configured to generate the electrical shunt-current, and wherein the electrically insulative layer is configured to mitigate the electrical shunt-current flowing from the second IMD to the first IMD through the outer housing of the first IMD.

3. The system of claim 1, wherein the electrically conductive layer comprises at least one of titanium or stainless steel.

4. The system of claim 1, wherein the electrically insulative layer comprises at least one of aluminum oxide, silicon dioxide, silicon nitride, aluminum nitride, titanium dioxide, or diamond.

5. The system of claim 1, wherein the electrically insulative layer comprises an electrically insulative polymer.

6. The system of claim 5, wherein the polymer comprises at least one of silicone, polycarbonate, or a biocompatible thermoplastic.

7. The system of claim 1, wherein the outer housing further comprises a third layer formed over the electrically insulative layer, the electrically insulative layer being positioned between the third layer and the electrically conductive layer.

8. The system of claim 7, wherein the third layer comprises metal.

9. The system of claim 7, wherein the electrically insulative layer comprises a first electrically insulative layer, and wherein the third layer comprises a second electrically insulative layer.

10. The system of claim 1, wherein the electrically insulative layer comprises a thickness of approximately 2.54 micrometers to approximately 1016 micrometers.

11. The system of claim 1, wherein the first tissue site comprises at least one of a nonmyocardial tissue site or a nonvascular cardiac tissue site.

12. The system of claim 1, wherein the first tissue site comprises at least one of an extravascular tissue site or a tissue site proximate to a nerve of the patient.

13. The system of claim 1, wherein the first implantable medical device (IMD) is electrically coupled to an electrode and comprises a processor enclosed within the outer housing and shunt-current mitigation circuitry coupled to the electrode, wherein the shunt-current mitigation circuitry is configured to reduce shunt-current that is introduced into the first IMD via the electrode, and wherein the shunt-current mitigation circuitry comprises a monitor electrically coupled to the electrode via a wire and a switch coupled to the monitor, wherein the monitor is configured to monitor an electrical parameter value at the electrode, and wherein the processor is configured to open the switch when the electrical parameter value is greater than or equal to a threshold value.

14. The system of claim 13, wherein the shunt-current mitigation circuitry further comprises at least one of a resistor or an inductor coupled to the switch.

15. The system of claim 13, wherein the second implantable medical device (IMD) is configured to transmit a communication signal to the processor that indicates prospective therapy delivery to the patient by the second IMD, and wherein the processor is configured to open the switch in response to receiving the communication signal from the second IMD.

16. The system of claim 13, wherein the electrode comprises a first electrode, and wherein the first implantable medical device is electrically coupled to a second electrode, and wherein the electrical parameter value comprises at least one of a voltage at the first electrode, a current through the first electrode or a voltage across at least the first and second electrodes.

17. The system of claim 1, wherein the second implantable medical device comprises an implantable cardiac device that is configured to deliver at least one of a pacing, cardioversion or defibrillation therapy to a heart of a patient.

18. The system of claim 1, wherein the first implantable medical device comprises at least one of an implantable electrical stimulator or an implantable neurostimulator.

19. The system of claim 1, wherein the first IMD is configured to communicate with the second IMD directly or via a programmer.

20. A system comprising:

a first implantable medical device (IMD) configured to deliver electrical stimulation to a first tissue site within a patient, wherein the first IMD comprises an outer housing that includes an electrically conductive portion;

an electrically insulative pouch physically separate from the first IMD and substantially fully encapsulating at least the electrically conductive portion of the outer housing, wherein the electrically insulative pouch is configured to reduce electrical shunt-current to the electrically conductive layer; and

a second IMD configured to deliver electrical stimulation to a second tissue site within the patient.

21. The system of claim 20, wherein the second implantable medical device (IMD) is configured to generate the electrical shunt-current, and wherein the electrically insulative pouch is configured to mitigate or substantially eliminate electrical shunt-current from flowing from the second IMD to the first IMD through the outer housing of the first IMD.

22. The system of claim 20, wherein the electrically insulative pouch comprises at least one of silicone, polycarbonate, or a biocompatible thermoplastic.

23. The system of claim 20, wherein the first IMD is configured to communicate with the second IMD directly or via a programmer.

24. A method of reducing electrical shunt-current between a first implantable medical device (IMD) configured to deliver electrical stimulation to a first tissue site within a patient and a second IMD configured to deliver electrical stimulation to a second tissue site within the patient, wherein the first IMD and second IMD are implanted within the patient, the method comprising substantially fully covering at least one of an internal surface or an external surface of an electrically conductive layer of an outer housing of the first IMD with at least one of an electrically insulative layer or an electrically insulative pouch, wherein the at least one of the electrically insulative layer or the electrically insulative pouch is configured to mitigate electrical shunt-current flowing to the electrically conductive layer.

25. The method of claim 24, wherein substantially fully covering at least one of an internal surface or an external surface of the electrically conductive layer of the outer housing of the first implantable medical device (IMD) with an electrically insulative layer comprises substantially fully covering at least one of an internal surface or an external surface of the electrically conductive layer of the outer housing of the first IMD with at least one of aluminum oxide, silicon dioxide, silicon nitride, aluminum nitride, titanium dioxide, or diamond.

26. The method of claim 24, wherein substantially fully covering at least one of an internal surface or an external surface of the electrically conductive layer of the outer housing of the first implantable medical device (IMD) with an electrically insulative layer comprises substantially fully covering at least one of an internal surface or an external surface of the electrically conductive layer of the outer housing of the first IMD with silicone.

27. The method of claim 24, wherein the first implantable medical device (IMD) comprises a processor enclosed within the outer housing, an electrode, and shunt-current mitigation circuitry coupled to the electrode, wherein the shunt-current mitigation circuitry is configured to reduce a shunt-current that is introduced into the first IMD via the electrode, wherein the shunt-current mitigation circuitry comprises a monitor electrically coupled to the electrode via a wire, wherein the monitor is configured to monitor an electrical parameter value at the electrode and a switch coupled to the monitor, and wherein the processor is configured to open the switch when the electrical parameter value is greater than or equal to a threshold value.

28. A method comprising:

implanting in a body of a patient a first implantable medical device (IMD) that delivers electrical stimulation to a first tissue site within the patient, wherein the first IMD comprises an outer housing that comprises an electrically conductive layer comprising an internal surface and an external surface and an electrically insulative layer substantially fully covering at least one of the internal surface or the external surface of the electrically conductive layer, wherein the electrically insulative layer is configured to reduce electrical shunt-current flowing through the outer housing of the first IMD; and

implanting in the body of the patient a second IMD that delivers electrical stimulation to a second tissue site within the patient.

29. The method of claim 28, wherein the electrically insulative layer comprises at least one of aluminum oxide, silicon dioxide, silicon nitride, aluminum nitride, titanium dioxide, or diamond.

30. The method of claim 28, wherein the electrically insulative layer comprises at least one of silicone, polycarbonate, or a biocompatible thermoplastic.

31. A system comprising:

a first means for delivering electrical stimulation to a first tissue site within a patient,

wherein the first means for delivering electrical stimulation comprises;

an outer housing means for housing components of the first IMD, wherein the outer housing means for housing components of the first IMD comprises;

a means for defining an internal surface and an external surface, wherein the means for defining is electrically conductive, and

a means for electrically insulating the means for defining, wherein the means for electrically insulating substantially fully covers at least one of the internal surface or the external surface of the means for defining, and wherein the means for electrically insulating the means for defining is configured to mitigate electrical shunt-current flowing through the outer housing means of the first IMD; and

a second means for delivering electrical stimulation to a second tissue site within the patient.

32. The system of claim 31, wherein the means for electrically insulating comprises at least one of silicone, polycarbonate, a biocompatible thermoplastic, aluminum oxide, silicon dioxide, silicon nitride, aluminum nitride, titanium dioxide, or diamond.